Delivery Order SPE2DB22D1106-SPE2DB25FEGV5

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,647.19 for the supply of 4568257840 - CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of May 16, 2025 and was awarded on May 15, 2025. The contract is not set aside and is a part of Amerisourcebergen's larger $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,893.43, is for the delivery of 4566327828 - CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of November 5, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.10 firm-fixed-price delivery order covers the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,700.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567254829 CLOMID 50 MG TABLET UD 30S. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CLOMID 50 MG TABLET UD 30S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,403.23 and a completion date of May 21, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,311.40, is for the provision of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of April 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,879.07, is for the delivery of CLOMID 50 MG TABLET UD 30S. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 17, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,316.60 for the supply of 4,568,385,890 units of the medication CLOMID 50 MG TABLET UD 30S. The period of performance runs through May 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor and holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,179.02 firm fixed-price delivery order covers the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a performance period through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $5,148.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CLOMID 50 MG TABLET UD 30S. The contract is a Firm Fixed Price Delivery Order that runs through April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGV5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,615.54, is for the supply of 4567845711 - CLOMID 50 MG TABLET UD 30S. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:40 PM